Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance.

Bogale DE

Open source

DOI
10.1016/j.ctarc.2026.101340
Published
2026
Container
Cancer treatment and research communications
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101340,
  title = {Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance.},
  author = {Bogale DE},
  year = {2026},
  journal = {Cancer treatment and research communications},
  doi = {10.1016/j.ctarc.2026.101340},
  url = {https://doi.org/10.1016/j.ctarc.2026.101340}
}

RIS

TY  - JOUR
TI  - Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance.
AU  - Bogale DE
PY  - 2026
JO  - Cancer treatment and research communications
DO  - 10.1016/j.ctarc.2026.101340
UR  - https://doi.org/10.1016/j.ctarc.2026.101340
ER  - 

APA

DE, B. (2026). Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101340

Source records